These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26558808)

  • 1. Visual Field Loss in a Case of Recurrent Cystic Craniopharyngioma During Concomitant Treatment With Pegylated Interferon α-2b.
    Tiedemann LM; Manley P; Smith ER; Dagi LR
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):e26-8. PubMed ID: 26558808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated interferon-α-2b for children with recurrent craniopharyngioma.
    Yeung JT; Pollack IF; Panigrahy A; Jakacki RI
    J Neurosurg Pediatr; 2012 Dec; 10(6):498-503. PubMed ID: 23061825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracystic interferon-α treatment leads to neurotoxicity in craniopharyngioma: case report.
    Sharma J; Bonfield CM; Singhal A; Hukin J; Steinbok P
    J Neurosurg Pediatr; 2015 Sep; 16(3):301-4. PubMed ID: 26023721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracystic interferon therapy in childhood craniopharyngioma: who, when and how?
    Bailey S; Parkes J
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):29-34. PubMed ID: 25059106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas.
    Jakacki RI; Cohen BH; Jamison C; Mathews VP; Arenson E; Longee DC; Hilden J; Cornelius A; Needle M; Heilman D; Boaz JC; Luerssen TG
    J Neurosurg; 2000 Feb; 92(2):255-60. PubMed ID: 10659012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic craniopharyngioma: intratumoral chemotherapy with alpha interferon.
    Dastoli PA; Nicácio JM; Silva NS; Capellano AM; Toledo SR; Ierardi D; Cavalheiro S
    Arq Neuropsiquiatr; 2011 Feb; 69(1):50-5. PubMed ID: 21359423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasculopathy after intracystic bleomycin administration for a recurrent cystic craniopharyngioma: case report.
    Cho WS; Kim SK; Wang KC; Phi JH; Cho BK
    J Neurosurg Pediatr; 2012 Apr; 9(4):394-9. PubMed ID: 22462704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoural bleomycin as a treatment for recurrent cystic craniopharyngioma. Case report and review of the literature.
    Alén JF; Boto GR; Lagares A; de la Lama A; Gómez PA; Lobato RD
    Neurocirugia (Astur); 2002 Dec; 13(6):479-85; discussion 485. PubMed ID: 12529778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracystic treatments for craniopharyngioma.
    Steinbok P; Hukin J
    Neurosurg Focus; 2010 Apr; 28(4):E13. PubMed ID: 20367357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of irreversible leukoencephalopathy in a patient with C virus hepatitis treated with pegylated interferon-alpha-2b and ribavirin.
    Iacob SA; Petrescu AM; Iacob DG
    Rom J Intern Med; 2013; 51(3-4):197-200. PubMed ID: 24620633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of pegylated interferon-alpha-2b in young patients with plexiform neurofibromas.
    Jakacki RI; Dombi E; Potter DM; Goldman S; Allen JC; Pollack IF; Widemann BC
    Neurology; 2011 Jan; 76(3):265-72. PubMed ID: 21242495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirin.
    Santantonio T; Fasano M; Sagnelli E; Tundo P; Babudieri S; Fabris P; Toti M; Di Perri G; Marino N; Pizzigallo E; Angarano G;
    Hepatology; 2014 Jun; 59(6):2101-9. PubMed ID: 24442928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.
    Tseng PL; Chen TC; Chien YS; Hung CH; Yen YH; Chang KC; Tsai MC; Lin MT; Lee CT; Shen CH; Hu TH
    Am J Kidney Dis; 2013 Oct; 62(4):789-95. PubMed ID: 23746377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma. Report of three cases.
    Lafay-Cousin L; Bartels U; Raybaud C; Kulkarni AV; Guger S; Huang A; Bouffet E
    J Neurosurg; 2007 Oct; 107(4 Suppl):318-23. PubMed ID: 17941498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdomyolysis associated with the co-administration of daptomycin and pegylated interferon α-2b and ribavirin in a patient with hepatitis C.
    Colomba C; Rubino R; Siracusa L; Mazzola G; Titone L
    J Antimicrob Chemother; 2012 Jan; 67(1):249-50. PubMed ID: 21965434
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of inflammation in the genesis of the cystic component of craniopharyngiomas.
    Pettorini BL; Inzitari R; Massimi L; Tamburrini G; Caldarelli M; Fanali C; Cabras T; Messana I; Castagnola M; Di Rocco C
    Childs Nerv Syst; 2010 Dec; 26(12):1779-84. PubMed ID: 20668862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pediatric craniopharyngioma: long-term results in 61 cases].
    Pancucci G; Massimi L; Caldarelli M; D'Angelo L; Sturiale C; Tamburrini G; Tufo T; Di Rocco C
    Minerva Pediatr; 2007 Jun; 59(3):219-31. PubMed ID: 17519867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taste disturbances during therapy with pegylated interferon-alpha 2b and ribavirin in patients with chronic hepatitis C.
    Klimacka-Nawrot E; Musialik J; Suchecka W; Petelenz M; Hartman M; Lichtański P; Błońska-Fajfrowska B
    Wiad Lek; 2010; 63(4):289-99. PubMed ID: 21608370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.
    Goldman S; Pollack IF; Jakacki RI; Billups CA; Poussaint TY; Adesina AM; Panigrahy A; Parsons DW; Broniscer A; Robinson GW; Robison NJ; Partap S; Kilburn LB; Onar-Thomas A; Dunkel IJ; Fouladi M
    Neuro Oncol; 2020 Nov; 22(11):1696-1704. PubMed ID: 32393959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thyroid dysfunctions in children with chronic hepatitis C during interferon alpha-2b therapy].
    Kupś-Rzepecka J; Woźniakowska-Gesicka T; Gołabek V
    Przegl Lek; 2011; 68(6):311-5. PubMed ID: 22039668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.